Multiple Sclerosis

Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.

Feb 18, 2024

Establishing biomarkers to predict multiple sclerosis diagnosis and prognosis has been challenging using a single biomarker approach. We hypothesised that a combination of biomarkers would increase th...

3D U-Net for automated detection of multiple sclerosis lesions: utility of transfer learning from other pathologies.

Nov 15, 2023

Deep learning algorithms for segmentation of multiple sclerosis (MS) plaques generally require training on large datasets. This manuscript evaluates the effect of transfer learning from segmentation o...

CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis.

Nov 15, 2023

Conventional type 1 dendritic cells (DC1) contribute to the development of pathogenic T helper type 1 (Th1) cells in part the production of the proinflammatory cytokine interleukin-12. Thus, depletio...

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective.

Jul 25, 2023

Wnt/β-catenin (WβC) signaling pathway is an important signaling pathway for the maintenance of cellular homeostasis from the embryonic developmental stages to adulthood. The canonical pathway of Wβ...

Blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis: A non-inferiority RCT.

Jul 25, 2023

Cognitive behavioural therapy (CBT) reduces multiple sclerosis (MS)-related fatigue. Implementation of face-to-face CBT is hindered by limited treatment capacity and traveling distances to treatment l...

Q&A: Planning Crucial to ‘Optimize’ Care of MS-Related Reproductive Issues

May 29, 2023

For patients with MS, the potential impact of disease-modifying therapies on fertility and maternal and fetal health makes pre-conception critical. The diagnosis of MS in young adults often...

Long Non-Coding RNAs BACE1-AS and BC200 in Multiple Sclerosis and their Relation to Cognitive function: A Gene Expression Analysis.

May 29, 2023

Cognitive impairment is a common and debilitating feature of multiple sclerosis (MS), and the dysregulation of synaptic plasticity is one of its direct causes. Long non-coding RNAs (lncRNAs) have been...

Neuroprotection in cerebral cortex induced by the pregnancy hormone estriol.

May 29, 2023

In multiple sclerosis (MS), demyelination occurs in cerebral cortex, and cerebral cortex atrophy correlates with clinical disabilities. Treatments are needed in MS to induce remyelination. Pregnancy i...

Natalizumab extended-interval dosing in a real-life setting.

May 22, 2023

Natalizumab is a high-efficacy therapy for recurrent multiple sclerosis (RMS) with a four-week administration interval. Controlled trials have shown that extending this interval to six weeks led to be...

The importance of the patient's perspective in decision-making in multiple sclerosis: Results of the OwnMS patient perspectives study.

May 22, 2023

Research is needed to identify the unmet disease education and communication needs of people with multiple sclerosis (PwMS) to support informed decision-making, enable self-management and maintain ind...

Epidemiology of demyelinating diseases in Mexico: A registry-based study.

May 15, 2023

Demyelinating diseases (DD) are a group of chronic neurological diseases associated with loss and injury of brain or spinal cord regions. These conditions could trigger impairment of neurological func...

Initial clinical and radiological features of patients with multiple sclerosis in Oman.

May 08, 2023

Multiple sclerosis (MS) is a lifelong demyelinating disorder with a varying disease course, resulting in different degrees of physical disability for affected patients. This study aimed to present the...

2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis.

May 08, 2023

Ca signaling is one of the essential signaling systems for T lymphocyte activation, the latter being an essential step in the pathogenesis of autoimmune diseases such as multiple sclerosis (MS). Store...

Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumes.

May 01, 2023

Vascular disease risk factors (VDRF) such as hypertension, hyperlipidemia, obesity, diabetes and heart disease likely play a role in disease progression in people with multiple sclerosis (PwMS) (Marri...

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis.

May 01, 2023

Tumour necrosis factor (TNF) is a pleiotropic cytokine and master regulator of the immune system. It acts through two receptors resulting in often opposing biological effects, which may explain the la...

History of the discovery and development of Biomodulina T (InmunyVital®), a useful immunomodulator with a broad range of clinical applications.

Apr 24, 2023

Biomodulina T (InmunyVital®) is a thymic factor that modulates immune response and inflammation. Biomodulina T stimulates the differentiation, maturation and proliferation of T cells. Additionally, B...

Cycling in primary progressive multiple sclerosis (CYPRO): study protocol for a randomized controlled superiority trial evaluating the effects of high-intensity interval training in persons with primary progressive multiple sclerosis.

Apr 24, 2023

Primary progressive multiple sclerosis (PPMS) is the least prevalent multiple sclerosis (MS) phenotype. For persons with PPMS (pwPPMS), pharmacological treatment options are limited. As a complementar...

Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis.

Apr 17, 2023

Previously, several studies investigated the effect of cladribine among patients with multiple sclerosis (MS) as a treatment option. Due to the contradictory results of previous studies regarding the ...

Neural network algorithms predict new diffusion MRI data for multi-compartmental analysis of brain microstructure in a clinical setting.

Apr 10, 2023

High angular resolution diffusion imaging (HARDI) is a promising method for advanced analysis of brain microstructure. However, comprehensive HARDI analysis requires multiple acquisitions of diffusion...

An investigation of auditory processing in relapsing-remitting multiple sclerosis.

Apr 03, 2023

Multiple sclerosis (MS) is one of the most common neurological diseases in North America and it is frequently associated with sensory processing difficulties, cognitive deficits, and psychiatric illne...